USD10
OCS Shares
About Oculis HoldingOculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

USD10
OCS Shares
About Oculis HoldingOculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Stats

TRADING WINDOW

Closed

OPENS AT

Apr 17 at 1:30 PM GMT+0

MARKET CAP

$1.59B

OPEN PRICE

Not enough data

LOW (1Y)

$16.00

HIGH (1Y)

$30.68

LOW (24H)

$27.00

HIGH (24H)

$27.72

VOLUME (24H)

$86.99K

25.38%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$27.67
1.07%
1 Week
$27.71
1.23%
1 Month
$26.01
5.23%
1 Year
$18.12
51.05%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.